Public recall detail

Auro-Losartan Product Recall (2021-05-27)

medium
Recall Safety notice
Quick summary

Quick summary: Auro-Losartan Product Recall (2021-05-27) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Auro-Losartan Product Recall (2021-05-27) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionA. Auro-Losartan 25 mg Tablet DIN, NPN, DIN-HIM DIN 02403323 Dosage form Tablet Strength Losartan Potassium 25 mg Lot or serial number WB2519001-A Companies Recalling Firm Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA Marketing Authorization Holder Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA B. Auro-Losartan 50 mg Tablet DIN, NPN, DIN-HIM DIN 02403331 Dosage form Tablet Strength Losartan Potassium 50 mg Lot or serial number WB5019001-A, WB5019001-B Companies Recalling Firm Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA Marketing Authorization Holder Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA C. Auro-Losartan 100 mg Tablet DIN, NPN, DIN-HIM DIN 02403358 Dosage form Tablet Strength Losartan Potassium 100 mg Lot or serial number WB1019001-A, WB1019001-B Companies Recalling Firm Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA Marketing Authorization Holder Auro Pharma Inc. 3700 Steeles Ave. W Woodbridge L4L 8K8 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...